International Jump Rope Union is Committed to Integrity and Clean Sport
IJRU is a proud supporter and co-signatory of the World Anti-Doping Agency (WADA) and its mission to protect the integrity of sport through doping-free competition. Established to bring consistency to anti-doping policies and regulations worldwide, WADA works with sport organizations and governments across the globe. IJRU has fully adopted WADA’s anti-doping policies and procedures for all IJRU World Championship events. In addition, IJRU provides its National Governing Body (NGB) members with access to WADA resources, including education, guidance, and official documentation which can be access on this page.
These Anti-Doping Rules are adopted and implemented in accordance with IJRU's responsibilities under the Code, and in furtherance of IJRU's continuing efforts to eradicate doping in sport.
Anti-Doping Information: Table of Contents
This Anti-Doping webpage contains information concerning:
What do you know about WADA, Anti-Doping, and Clean Sport?
The World Anti-Doping Agency (WADA) was founded with the aim of bringing consistency to anti-doping roles and regulations within sport organisations and governments across the world. The International Jump Rope Union (IJRU) is a full supporter of WADA. IJRU has adopted WADA’s anti-Doping policies and procedures for all IJRU’s World Championship events. This includes the use of the WADA Code and the eight International Standards:
Background: Code Article 18.2 makes it mandatory for IJRU education programs to include several awareness, information and values-based education components. The minimum requirement is for this material to be available on the IJRU website.
Requirements: The Code and the International Standard for Education (ISE Article 5.2) outline the topics that must be included in an IJRU education program and, at minimum, on the IJRU’s website. This includes:
Principles and values associated with clean sport
Athletes’, athlete support personnel’s and other groups’ rights and responsibilities under the Code
The principle of Strict Liability
Consequences of doping, for example, physical and mental health, social and economic effects, and sanctions
Anti-Doping Rule Violations (ADRVs)
Substances and methods on the Prohibited List
Risks of supplement use
Use of medications and Therapeutic Use Exemptions, (TUEs)
Testing procedures, including urine, blood and the Athlete Biological Passport (ABP)
Requirements of the Registered Testing Pool (RTP), including whereabouts and the use of ADAMS
Coming forward to share concerns about doping
What is Doping?
Doping is not just a positive test showing the presence of a prohibited substance in an athlete’s test sample. Doping is defined as the occurrence of one or more of the 11 Anti-Doping Rule Violations (ADRVs) outlined in the World Anti-Doping Code and IJRUs Anti-Doping Rules These are:
1. Presence of a prohibited substance, its metabolites or markers in an athlete’s sample
2. Use or attempted use of a prohibited substance or method by an athlete
3. Refusing, evading or failing to submit to sample collection by an athlete
4. Failure to file whereabouts information and/or missed tests by an athlete
5. Tampering or attempted tampering with the doping control process by an athlete or other person
6. Possession of a prohibited substance or method by an athlete or athlete support personnel
7. Trafficking or attempted trafficking of a prohibited substance or method by an athlete or other person
8. Administering or attempting to administer a prohibited substance or method to an athlete
9. Complicity or attempted complicity in an ADRV by an athlete or other person
10. Prohibited Association by an athlete or other person with a sanctioned athlete support personnel member
11. Acts to discourage or retaliate against reporting to authorities
Refer to: At-a-Glance: Anti-Doping Overview | World Anti Doping Agency (wada-ama.org)
Why is Doping Prohibited?
The use of doping substances or doping methods to enhance performance is fundamentally wrong and is detrimental to the overall spirit of sport. Drug misuse can be harmful to an athlete's health and to other athletes competing in the sport. It severely damages the integrity, image, and value of sport, whether the motivation to use drugs is to improve performance. To achieve integrity and fairness in sport, a commitment to clean sport is critical.
What is Strict Liability?
What does ‘Strict Liability’ mean?
The principle of strict liability applies to all athletes who compete in any sport with an anti-doping program. It means that athletes are responsible for any prohibited substance, or its metabolites or markers found to be present in their urine and/or blood sample collected for testing during doping control, regardless of whether the athlete intentionally or unintentionally used a prohibited substance or method. Therefore, it is important to remember that it is each athlete’s ultimate responsibility to know what enters their body.
The rule which provides that principle, under Code Article 2.1 and Article 2.2, states that it is not necessary that intent, fault, negligence, or knowing use on the athlete’s part be demonstrated by the Anti-Doping Organization to establish an anti-doping rule violation.
Why is Doping Dangerous?
Doping can result in severe health consequences but also comes with sport, social, financial and legal consequences. For an athlete, doping could spell the end of their sporting career, reputation, and prospects both in and out of sport.
Sport Consequences
Sanctions for an Anti-Doping Rule Violation (ADRV) can include:
Provisional Suspension. The athlete or other person is temporarily banned from participating in any competition or activity while waiting for the results management process to be complete or until the final decision is rendered.
Ineligibility. The athlete or other person is not allowed to compete or participate in any other activity, such as training, coaching, or even access to funding due to an ADRV. This period of ineligibility can be for up to 4 years or even life depending on the circumstances of the ADRV.
Disqualification of results. The athlete’s results during a particular period, competition or event are invalidated, which comes with forfeiture of any medals, points and prizes.
Public Disclosure. The International Jump Rope Union informs the public of the ADRV. This is done through publication in the IJRU Newsletter and by posting the athlete’s name and other information on the IJRU website “sanctioned” page. The posting can last for a period of 10 or more years.
Fines.
Health Consequences
The health consequences to an athlete can include:
Physical health. Medications and medical interventions have been developed to treat a particular condition or illness. Not an otherwise healthy athlete. Depending on the substance, the dosage and the consumption frequency, doping products may have particularly negative side effects on health.
Psychological health. Some doping substances may have an impact on the athlete’s mental health. Anxiety, obsessive compulsive disorders or psychosis are direct consequences from doping.
Financial Consequences
The financial consequences of doping can include:
Fines that IJRU Anti-Doping may have included in their anti-doping rules including costs associated with an Anti-Doping Rule Violation (ADRV).
Loss of income/financial support, such as government funding, other forms of financial support and by not participating in the competitions.
Loss of financial support due to withdrawal of sponsor.
Requirement to reimburse sponsor, if included in the contract.
Reimbursement of prize money.
Impact of damaged reputation on future career prospects.
Legal Consequences
In addition to the sport, health, social and financial consequences listed above, doping can come with other legal consequences, such as:
Some countries have gone beyond the World Anti-Doping Code and made using a prohibited substance a criminal offense (e.g. Austria, Italy, France). (Know the rules of your country.)
In some countries, ADRVs related to trafficking, possession or administering a prohibited substance or some substances on the Prohibited List are considered a criminal offense.
What do athletes and athlete support personnel need to know about anti-doping and what is an athlete’s biological passport, ABP?
Athletes, their support personnel and others who are subject to anti-doping rules all have rights and responsibilities under the World Anti-Doping Code (Code). Part Three of the Code outlines all the roles and responsibilities of each stakeholder in the anti-doping system.
Athletes’ Rights
“Every athlete has the right to clean sport!”
Ensuring that athletes are aware of their rights and that these rights are respected is vital to the success of clean sport. WADA’s Athlete Committee (now Athlete Council) drafted the Athletes’ Anti-Doping Rights Act (Act). This Act is made up of two parts. Part, one sets out rights that are found in the Code and International Standards. Part two sets out recommended athlete rights that are not found in the Code or International Standards but are rights that athletes recommend that Anti-Doping Organizations (ADOs) adopt for best practice.
Athlete rights outlined in the Code include:
Equal opportunities in their pursuit of sport, free of participation by other athletes who dope
Equitable and fair testing programs
A Therapeutic Use Exemption (TUE) application process
To be heard, to have a fair hearing within a reasonable time by a fair, impartial and operationally independent hearing panel, with a timely reasoned decision specifically including an explanation of the reasons of the decision
Right to appeal the hearing decision
IJRU has jurisdiction over Jump Rope will be accountable for its action and an athlete shall have the ability to report any compliance issue
Ability to report Anti-Doping Rule Violations (ADRVs) through an anonymous mechanism and not be subjected to threats or intimidation
Receiving anti-doping education
Fair handling of their personal information by IJRU in accordance with the International Standard for the Protection of Privacy and Personal Information (ISPPPI) and any local applicable law
To pursue damages from another athlete whose actions have damaged that athlete by the commission of an ADRV
During the sample collection process, athletes have the right to:
See the identification of the Doping Control Officer (DCO)
Request additional information about the sample collection process, about the authority under which it will be carried out and on the type of sample collection
Hydrate and have fluids in immediate proximity for consumption.
Be accompanied by a representative and, if available, an interpreter
Request a delay in reporting to the doping control station for valid reasons (International Standard for Testing and Investigations Art. 5.4.4)
Request modifications for athletes with impairments (if applicable)
Be informed of their rights and responsibilities
Receive a copy of the records of the process
Have further protections for "protected persons” because of their age or lack of legal capacity
Request and attend the B sample analysis (in the case of an Adverse Analytical Finding)
Athlete Biological Passport (ABP)
The Athlete Biological Passport (ABP) was introduced in 2009 and is a pillar method in the detection of doping. It is an individual electronic profile that monitors selected athlete biological variables that indirectly reveal the effects of doping. ABP is integrated directly into ADAMS.
What are Athletes’ and Athlete Support Personnel Rights and Responsibilities?
Athletes’ Responsibilities
Athletes’ rights to clean sport come with corresponding responsibilities, and athletes may be tested in- and out-of-competition, anytime, anywhere and with no advance notice.
Their clean sport responsibilities include (but are not limited to):
Complying with the IJRUs Anti-Doping Rules [and relevant policies if applicable] (in line with the World Anti-Doping Code)
Being available for sample collection (urine, blood or dried blood spot (DBS)), whether in-competition or out-of-competition
Always remaining within direct observation of the Doping Control Officer (DCO) or chaperone from notification until the completion of the sample collection process
Providing identification upon request during the sample collection process
Ensuring that no prohibited substance enters their body and that no prohibited method is used on them https://www.wada-ama.org/en/prohibited-list
Ensuring that any treatment is not prohibited according to the Prohibited List [https://www.wada-ama.org/en/prohibited-list] in force and checking this with the prescribing physicians, or directly with IJRU Anti-Doping if necessary.
Applying to the relevant ADO if no alternative permitted treatment is possible and a Therapeutic Use Exemption (TUE) is required (see the IJRU or NADO’s TUE application process) IJRU TUE’s can be submitted to: TUE@ijru.sport
Reporting immediately for sample collection after being notified of being selected for doping control testing.
Ensuring the accuracy of the information entered on the Doping Control Form (DCF)
Cooperating with IJRU’s investigating ADRVs
Not working with coaches, trainers, physicians or other athlete support personnel who are ineligible on account of an ADRV or who have been criminally convicted or professionally disciplined in relation to doping (see WADA’s Prohibited Association List)
Athlete Support Personnel Rights
Athlete support personnel and other persons also have rights and responsibilities under the Code. These include:
Right to a fair hearing, before an independent hearing panel
Right to appeal the hearing decision
Rights regarding data protection, according to the ISPPPI and any local applicable law.
Athlete Support Personnel Responsibilities
Athlete support personnel’s responsibilities under the Code include:
Using their influence on athlete values and behaviors to foster clean sport behaviors
Knowing and complying with all applicable anti-doping policies and rules, including the IJRU Anti-Doping Rules [and relevant policies if applicable] (in line with the Code)
Cooperating with the athlete doping control program
Cooperating with IJRUs investigating Anti-Doping Rule Violations (ADRVs)
Informing IJRU and/or NADO if they have committed an ADRV in the last 10 years
Refraining from possessing a prohibited substance (or a prohibited method) *, administering any such substance or method to an athlete, trafficking, covering up an anti-doping rule violation (ADRV) or other forms of complicity and associating with a person convicted of doping (prohibited association). These are ADRVs applicable to athlete support personnel under Article 2 of the World Anti-Doping Code and Article X of the IJRUs Anti-Doping Rules.
* Unless the athlete support personnel can establish that the possession is consistent with a TUE granted to an athlete or other acceptable justification. Acceptable justification would include, for example, a team doctor carrying prohibited substances for dealing with acute and emergency situations.
IJRUs Recommendation to Athlete Support Personnel
Here are some ways athlete support personnel can support their athletes in their education on clean sport:
Share the Athlete’s Anti-Doping Rights Act with your athletes
Register and take a course suitable to you on the WADA’s ADEL platform
Follow IJRU on Twitter, Facebook and Instagram where the mail updates about anti-doping will be published.
Contact info@ijru.sport for any questions you may have.
What Organisations are involved in protecting clean sport?
World Anti-Doping Agency (WADA)
WADA was established in 1999 as an international independent agency to lead a collaborative worldwide movement for doping-free sport. WADA’s governance and funding are based on equal partnership between the Sport Movement and Governments of the world.
WADA’s primary role is to develop, harmonize and coordinate anti-doping rules and policies across all sports and countries. WADA’s key activities include:
Scientific and social science research
Education
Intelligence & investigations
Development of anti-doping capacity and capability
Monitoring of compliance with the World Anti-Doping Program
For more information about WADA, consult:
WADA’s website – www.wada-ama.org
International Federation (IF)
As the International Federation for the sport of Jump Rope, IJRU is responsible for implementing an effective and Code-compliant anti-doping program for jump rope. Under the World Anti-Doping Code (Code), IJRU is required to carry out the following anti-doping activities:
Providing education programs
Analyzing the risk of doping in their sport
Conducting in-competition and out-of-competition testing
Management of Therapeutic Use Exemptions (TUEs) for international-level athletes
Results Management including sanctioning those who commit Anti-Doping Rule Violations (ADRVs)
If you have any anti-doping queries, please contact info@ijru.sport, for TUEs information contact TUE@jru.sport
National Anti-Doping Organisations (NADOs)
NADOs are organisations designated by each country as possessing the primary authority and responsibility to:
Adopt and implement anti-doping rules at a national level
Plan and carry out anti-doping education
Plan tests and adjudicate anti-doping rule violations at a national level
Test athletes from other countries competing within that nation’s borders if required to
Check the list of NADOs to find out who to contact in your country.
If a NADO has not been designated in a country, the National Olympic Committee (NOC) takes over these responsibilities.
Regional Anti-Doping Organizations (RADOs)
In several regions of the world, countries have pooled their resources together to create a RADO responsible for conducting anti-doping activities in the region in support of NADOs.
RADOs bring together geographically clustered groups of countries where there are limited or no anti-doping activities, for which they take over responsibility, including:
Providing anti-doping education for athletes, coaches and support personnel
Testing athletes
Training of local sample collection personnel (doping control officers/chaperones)
An administrative framework to operate within
Link to WADA Documents
Background
Links to WADA’s website, the Code, International Standards, resources and other important WADA tools have been included throughout this document. While an athlete or even their support personnel may not consult the Code or the International Standards on a regular basis (or even ever in some cases) it is important that they know where to go when they do need to consult them. Additionally, many of these documents are available in other languages.
International Standard for Testing and Investigations (ISTI)
International Standard for Therapeutic Use Exemptions (ISTUE)
International Standard for the Protection of Privacy and Personal Information (ISPPPI)
International Standard for Code Compliance by Signatories (ISCCS)
Useful Online Databases
The following National Anti-Doping Organizations make online country-specific drug reference databases available for checking the status of a medication bought in that country.
The Prohibited List
The Prohibited List (List) identifies substances and methods prohibited in-competition, at all times (i.e. in- and out-of-competition) and in particular sports. Substances and methods are classified by categories (e.g. steroids, stimulants, masking agents). The List is updated at least annually following an extensive consultation process facilitated by WADA.
It is each athlete’s responsibility to ensure that no prohibited substance enters his/her body and that no prohibited method is used.
The List only contains the generic names of the pharmaceutical substances. The List does not contain brand names of the medications, which vary from country to country. Before taking any medication, an athlete should check with the prescribing physician that it does not contain a prohibited substance:
Check that the generic name or International Non-proprietary Name (INN) of any active ingredient is not prohibited (‘in-competition only’ or at ‘all times’).
Check that the medication does not contain any pharmaceutical substances that would fall within a general category that is prohibited. Many sections of the Prohibited List only contain a few examples and state that other substances with a similar chemical structure or similar biological effect(s) are also prohibited.
Be aware that intravenous infusions and/or injections of more than 50mL per 6-hour period are prohibited, regardless of the status of the substances.
Be aware that since 1 January 2022, all injectable routes of administration will now be prohibited for glucocorticoids during the in-competition period.
Note: Oral administration of glucocorticoids remains prohibited in-competition. Other routes of administration are not prohibited when used within the manufacturer’s licensed doses and therapeutic indications.
Be aware that as of 1 January 2024, the narcotic tramadol will be prohibited in-competition
If you have any doubt, contact IJRU/NADO.
An athlete will only be allowed to use a prohibited substance for medical reasons if the athlete has a valid Therapeutic Use Exemption (TUE) for the substance that IJRU/NADO has granted or recognized.
Therapeutic Use Exemptions (TUE) Guidelines and Application
The International Standard for Therapeutic Use Exemptions (ISTUE) was created with the understanding that, due to illness or medical condition, an Athlete may require the Use of medications or treatments on the World Anti-Doping Agency’s (WADA’s) Prohibited List.
Anti-Doping Rule Violations
Rule violations that apply to support personnel, coaches and medical professionals
Speak Up, Play Clean, Privacy Reporting Form
IJRU is committed to protecting clean athletes and ensuring fair competition. Use this form to confidentially report suspected doping offenses. You may remain anonymous, or provide your contact information if you wish to communicate directly with IJRU’s Investigation Team.
Risks of Supplement Use
Extreme caution is recommended regarding supplement use. A number of positive tests have been attributed to the misuse of supplements, poor labeling or contamination of dietary supplements.
The use of supplements by athletes is a concern because in many countries the manufacturing and labeling of supplements may not follow strict rules, which may lead to a supplement containing an undeclared substance that is prohibited under anti-doping regulations. Pleading that a poorly labeled dietary supplement was taken is not an adequate defense in a doping hearing.
Risks of supplements include:
Manufacturing standards, which are often less strict when compared with medications. These lower standards often lead to supplement contamination with an undeclared prohibited substance, for example when manufacturing equipment isn't cleaned to the required standards and contains remnants of ingredients from a previous product.
Fake or low-quality products which may contain prohibited substances and be harmful to health.
Mislabeling of supplements with ingredients wrongly listed and prohibited substances not identified on the product label.
False claims that a particular supplement is endorsed by Anti-Doping Organizations (ADOs) or that it is “safe for athletes”. Remember, ADOs do not certify supplements, and the product label may contain misleading messaging.
Regarding Supplements, Energy Drinks, and Herbal Medicines:
Supplements and energy drinks, unlike pharmaceuticals, are classified as “foods” and are not required to list all ingredients of their product labels.
As there may be substances present that are not indicated on the label or packaging, even if you provide the product name, it still may be difficult to determine whether the product contains any prohibited substances.
Similarly, for herbal medicines and other products derived from plants, animals, or natural sources, the composition may vary depending on factors such as the origin of the raw materials, the time of harvest, and the extraction method used.
Therefore, it cannot be determined with certainty that a product does not contain prohibited substances.
Athletes should do a risk-benefit assessment if they are considering the use of supplements. The first step of such an assessment is to consider whether a “food-first” approach meets the athlete’s needs. Whenever possible, such assessment should be done with a support of a certified nutritionist or other qualified professional who is familiar with the global and [IJRU /NADO] Anti-Doping Rules.
Checking your supplements
If, after careful consideration, an athlete chooses to use supplements, they must take the necessary steps to minimize the risks associated with supplements. This includes:
Thorough research on the type and dose of the supplement, preferably with the advice of a certified nutritionist or other qualified professional who is familiar with Anti-Doping Rules.
Only selecting supplements that have been “batch-tested” by an independent company.
Remembering what supplement they take, keep some of it in case they get a positive result, and keep any proof of purchase and declare it on the Doping Control Form (DCF).
Remember, no supplement is 100% risk-free but athletes and athlete support personnel can take certain steps to minimize these risks.
Neither WADA nor the IJRU/NADO is involved in any supplement certification process and therefore do not certify or endorse manufacturers or their products. WADA and IJRU/NADO do not control the quality or the claims of the supplements industry.
Testing
The aim of testing is to protect clean athletes through the detection and deterrence of doping.
Any athlete under the testing jurisdiction of IJRU may be tested at any time, with no advance notice, in- or out-of-competition, and be required to provide a urine, blood sample or blood for a Dried Blood Spot (DBS) analysis.
Sample Collection Process:
Athlete Selection: An athlete can be selected for testing at any time and any place.
Notification: A Doping Control Officer (DCO) or chaperone will notify the athlete of their selection and outline their rights and responsibilities.
Reporting to the Doping Control Station: The athlete should report to the doping control station immediately after being notified. The DCO may allow a delay in reporting for a valid reason.
Sample Collection Equipment: The athlete is given a choice of individually sealed sample collection vessels and kits to choose from.
The athlete must inspect the equipment and verify the sample code numbers.
Collecting the Sample
For a urine sample:
Providing the sample: The athlete will be asked to provide the sample under the direct observation of a DCO or witnessing chaperone of the same gender.
Volume: A minimum of 90mL is required for urine samples. If the first sample is not 90mL, the athlete may be asked to wait and provide an additional sample.
Splitting the sample: The athlete will split their sample into A and B bottles.
Sealing the samples: The athlete will seal the A and B bottles in accordance with the DCO’s instructions.
Measuring specific gravity: The DCO will measure the specific gravity of the sample to ensure it is not too dilute to analyze. If it is too dilute, the athlete may be asked to provide additional samples.
For a blood sample:
The athlete will be asked to remain seated and relaxed for at least 10 minutes before undergoing venipuncture (only for the Athlete Biological Passport (ABP) blood samples).
The Blood Collection Officer (BCO) will ask for the athlete’s non-dominant arm, apply a tourniquet to the upper arm, and clean the skin at the puncture site.
The BCO will draw blood from the athlete and fill each Vacutainer blood tube with the required volume of blood.
The BCO will place the Vacutainer tubes into the A and B kits (only one vial may be necessary if the blood sample is collected as part of an ABP program).
Completing the Doping Control Form (DCF): The athlete will check and confirm that all the information is correct, including the sample code number and their declaration of medications and/or products they have used. They will also be asked their consent for the use of the sample for research purposes. The athlete will receive a copy of the DCF and should keep it.
Laboratory Process: All samples are sent to WADA-accredited laboratories for analysis.
Whereabouts
What are testing pools and why are whereabouts important for clean sport?
Out-of-competition testing with no-advance notice is one of the most powerful means of deterrence and detection of doping. To support this type of testing, an IF creates testing pools as part of its testing program. At this stage of jump rope, the sport is growing and developing. Once the number of competitions have increased and it becomes necessary to follow the athlete’s whereabouts in ADAMS, the need for a Registered Testing Pool will need to be identified, developed, and managed.
How do athletes know they need to provide whereabouts?
When the time comes, Athletes who need to provide whereabouts in ADAMS will be notified by IJRU Anti-doping or the DCO in charge of the testing of their inclusion in a registered testing pool as well as what information exactly is required of the athlete, how to use ADAMS, deadlines to submit required information and any consequences if the information required is not submitted.
Results Management
Athletes who participate in IJRU events are supported by a standard testing process aimed at detecting and deterring doping, following the worldwide practices for testing and results management. Ongoing opportunities in education are provided in the effort to prevent doping in future generations and investment in research committed to advancing anti-doping science.
Sanctions
The following table lists sanctions issued under IJRU’s Anti-Doping Rules. Sanctions are published in accordance with the WADA Code.
Education Tools
IJRU Athletes, Coaches, and Support Personnel are encouraged to create their own ADEL user account on the ADEL platform. All Athletes and Coaches are a part of the IJRU Education Testing Pool. Having an ADEL account will allow you to access and complete appropriate courses that may be encouraged by IJRU or may be required by IJRU to take part in named events.
Courses currently suggested for completion include:
ADEL courses for athletes:
Privacy and Information Security Awareness for Athletes
Athlete’s Guide to the 2021 Code
At-a-Glance: Athlete Whereabouts
At-a-Glance: Therapeutic Use Exemptions (TUE)
At-a-Glance: Anti-Doping Overview
Dried Blood Spot (DBS) Testing – The Basics
Factsheet – Glucocorticoid Injections
ADEL for International-Level Athletes
Guide to the List 2023
ADEL for National-Level Athletes
ADEL for Registered Testing Pool Athletes
Welcome to Sport Values
Respect
Equity
Inclusion
ADEL for Talented Level Athletes
Recertification course for International-Level Athletes / National-Level Athletes
ADEL courses for athlete support personnel:
ADEL for High Performance Coaches
Factsheet for Medical Professionals – Glucocorticoid Injection
ADEL for Medical Professionals
ADEL for Medical Professionals at Major Games
ADEL for Parents of Elite Athletes
Athlete Support Personnel Guide to the Code 2021
Sport Values in Every Classroom
Additional Athlete Resources
Athletes are ambassadors and role models. They have an important responsibility in protecting the integrity of their sport. Part of that obligation means that you will now need to provide whereabouts details so that anti-doping authorities can better ensure all athletes play true.
The Athlete Webinar Series: The Athlete Webinar Series are videos addressing specific topics to enhance knowledge on doping:
IJRU International Championship, Anti-Doping Post Event Evaluation
IJRU monitors Anti-Doping activities that occur during IJRU International Championship Events by conducting an “Antidoping Post Event Evaluation Report.” The results of this report should be completed within 2 -3 weeks following the completion of the event and returned to the Anti-Doping Panel and IJRU BOD for review and comments or action.
What was the name of the event?
What level event was this?
Did the event use IJRU event planning? (Was the event Sanctioned?)
What education took place for this event.
Where was the event held?
Describe any pre-planning.
Was a committee initiated?
Who was the agency doing the sample testing
Who was the agency contact.
Who oversaw the site testing
Was the event set up and planning in place for the event?
Were the testing rooms in good order?
Were there any unexpected issues?
Were there adequate volunteers for athlete chaperones?
How many athletes were tested?
What was the testing distribution plan?
Was ADAMS set up and used.
Where there any incidents with positive results.
What was the total invoice for testing
Who paid the testing bill.
What recommendations if any would you recommend going forward?
Challenges
What worked well
What can be improved
Recommendations for future growth and championship enhancement
Immediate action items of anti-Doping
Report Completed by
Date
Name
Report sent to Anti-Doping Panel, and IJRU BOD